217326-65-3

Basic information

• Product Name: 4-BROMOBENZO[D]OXAZOLE
• Synonyms: 4-BROMOBENZO[D]OXAZOLE;4-Bromo-1,3-benzoxazole;4-Bromobenzoxazole;4-Bromo-1,3-benzoxazole 98+%;Benzoxazole,4-broMo-;4-BroMo-benzooxazole
• CAS NO: 217326-65-3
• Molecular Formula: C7H4BrNO
• Molecular Weight: 198.02
• Mol File: 217326-65-3.mol

Chemical Properties

• Boiling Point: 251℃
• Flash Point: 106℃
• Appearance: /
• Density: 1.710
• Vapor Pressure: 0.033mmHg at 25°C
• Refractive Index: 1.649
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: -1.90±0.30(Predicted)
• CAS DataBase Reference: 4-BROMOBENZO[D]OXAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMOBENZO[D]OXAZOLE(217326-65-3)
• EPA Substance Registry System: 4-BROMOBENZO[D]OXAZOLE(217326-65-3)

Safety Data

• Hazardous Substances Data: 217326-65-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
4-Bromobenzo[d]oxazole is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its bromine atom allows for cross-coupling reactions, which are essential in the creation of complex drug molecules.
Used in Material Science:
4-Bromobenzo[d]oxazole is used as a building block in the development of new materials with specific properties. Its structure and reactivity make it a valuable component in the synthesis of advanced materials for various applications.
Used in Organic Chemistry Research:
4-Bromobenzo[d]oxazole is used as a reagent in organic chemistry research, where its unique properties can be exploited to study reaction mechanisms, develop new synthetic methods, or explore the properties of novel compounds.

InChI:InChI=1/C7H4BrNO/c8-5-2-1-3-6-7(5)9-4-10-6/h1-4H

Upstream product

• 116435-77-9 2-amino-3-bromophenol 
• 149-73-5 trimethyl orthoformate 
• 122-51-0 orthoformic acid triethyl ester 

Relevant articles and documents

METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS

Disclosed herein are methods of treating liver fibrosis by administering calpain inhibitors to subjects in need thereof.

CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF

Small molecule calpain modulator compounds, including their pharmaceutically acceptable salts, can be included in pharmaceutical compositions. The compounds can be useful in inhibiting calpain, or competitive binding with calpastatin, by contacting them with CAPN1, CAPN2, and/or CAPN9 enzymes residing inside a subject. The compounds and composition can also be administered to a subject in order to treat a fibrotic disease or a secondary disease state or condition of a fibrotic disease.

IMIDAZO [1,5-A]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

The invention provides substituted imidazo[1,5-a]pyrimidinyl carboxamide and related organic compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary substituted imidazo[1,5-a]pyrimidinyl carboxamide compounds described herein include substituted 2-heterocyclyl-4-alkyl-imidazo[1,5-a]pyrirnidine-8-carboxamide compounds and variants thereof.

BRIDGED BICYCLIC KALLIKREIN INHIBITORS

Provided herein are kallikrein modulating compounds, pharmaceutical compositions comprising the same, and uses thereof.